Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (201-210 of 377) with videos related to

Pageof 38
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyMatthias Eiber, Markus Kroenke, Alexander Wurzer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2023
Adoption of Lutetium-<sup>177</sup> PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020Luka Flegar, Smita George Thoduka, Damiano Librizzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
[<sup>68</sup>Ga]Ga-RAYZ-8009: A Glypican-3-Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging-A First-in-Human Case SeriesAlex J Poot, Constantin Lapa, Wolfgang A Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2023
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&TAmir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2024
Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranosticsSong Xue, Andrei Gafita, Yu Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2022
Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with <sup>177</sup>Lu-PSMA I&T therapySong Xue, Andrei Gafita, Chao Dong, et al.
BMC Cancer|May 24, 2017
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)Gregor Habl, Christoph Straube, Kilian Schiller, et al.
European Urology Oncology|October 24, 2022
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guidelineMarco M E Vogel, Mathias Düsberg, Lucia Stöhrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 27, 2012
First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnosesAlexander Drzezga, Michael Souvatzoglou, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, <sup>18</sup>F-rhPSMA-7, in Patients with Prostate CancerSo Won Oh, Alexander Wurzer, Eugene J Teoh, et al.
Pageof 38

Showing results (201-210 of 377) with videos related to

Sort By:
Pageof 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyMatthias Eiber, Markus Kroenke, Alexander Wurzer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 24, 2023
Adoption of Lutetium-<sup>177</sup> PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020Luka Flegar, Smita George Thoduka, Damiano Librizzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 12, 2024
[<sup>68</sup>Ga]Ga-RAYZ-8009: A Glypican-3-Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging-A First-in-Human Case SeriesAlex J Poot, Constantin Lapa, Wolfgang A Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2023
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&TAmir Karimzadeh, Paula Soeiro, Benedikt Feuerecker, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 9, 2024
Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranosticsSong Xue, Andrei Gafita, Yu Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2022
Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with <sup>177</sup>Lu-PSMA I&T therapySong Xue, Andrei Gafita, Chao Dong, et al.
BMC Cancer|May 24, 2017
Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)Gregor Habl, Christoph Straube, Kilian Schiller, et al.
European Urology Oncology|October 24, 2022
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guidelineMarco M E Vogel, Mathias Düsberg, Lucia Stöhrer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 27, 2012
First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnosesAlexander Drzezga, Michael Souvatzoglou, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
Quantitative and Qualitative Analyses of Biodistribution and PET Image Quality of a Novel Radiohybrid PSMA, <sup>18</sup>F-rhPSMA-7, in Patients with Prostate CancerSo Won Oh, Alexander Wurzer, Eugene J Teoh, et al.
Pageof 38